The World Federation of Hemophilia (WFH) was built on a foundation of "Treatment for All". See how Genentech is helping to make that a reality.
Genentech takes an industry-leading approach to patient advocacy. One that started, incidentally, with their entry to hemophilia.
Max, a musician with hemophilia A, takes a trip back in time to chat with his younger self about his experience with hemophilia and offers some sage advice.
Read how a group of experts from Genentech came together to deliver treatment during a pandemic.
Hear how Genentech is partnering with hemophilia chapters across the country to find ways to bring the community together, virtually.
Mark Skinner, former president of the World Federation of Hemophilia, discusses his goal to bring prevention and early intervention to the developing world.
How a unique organization is improving the lives of people with bleeding disorders by helping them achieve their goals.
Our Hemophilia Clinical Education Managers (CEMs) serve all 50 states and US territories. They have years of nursing/clinical experience with a host of helpful resources—and they can provide opportunities to connect with Genentech and the community at chapter events, conferences, and educational programs.
Clinical Education Managers do not provide medical advice.
Please enter your ZIP Code below.
Hear how our team of Hemophilia Community Clinical Education Managers provides support, in their own words.
Monitoring the safety of a drug during clinical trials AND after is called pharmacovigilance. “Pharma” comes from the Greek word “pharmakeia”—for drugs, medicines, or remedies. “Vigilance” is from the Latin “vigilantia,” meaning wakefulness, watchfulness, or attention.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.